Sage Journals: Discover world-class research

Abstract

MicroRNAs (MiRNAs) have been clarified as crucial regulators of the pathological processes in various carcinomas in the past years. Interestingly, existing evidence has manifested that microRNA-204-5p (miR-204-5p) is engaged in the initiation and progression of multiple carcinomas. However, the potential of miR-204-5p in cervical cancer remains to be disentombed. This study focused on unraveling the detailed role of miR-204-5p in cervical cancer. MiR-204-5p exhibited a low level in cervical cancer cells. The functional assays demonstrated that miR-204-5p upregulation exerted suppressive impact on the functions of cervical cancer cells, including proliferation, invasion, migration and epithelial-mesenchymal transition (EMT) process. Moreover, transcription factor AP-2 alpha (TFAP2A) was screened to be the most affected target gene by miR-204-5p, and TFAP2A was discovered to transcriptionally repress miR-204-5p in cervical cancer. The mutual regulation between TFAP2A and miR-204-5p was testified through molecular mechanism assays. Final rescued-function assays demonstrated that overexpression of TFAP2A could recover the suppressed cellular process caused by miR-204-5p upregulation. In conclusion, miR-204-5p/TFAP2A feedback loop promoted the proliferative and motorial capacities of cervical cancer cells. This finding suggested a novel modulatory loop of miR-204-5p/TFAP2A in cervical cancer, offering promising biomarkers for cervical cancer therapy.

Keywords

Cervical cancer miR-204-5p TFAP2A feedback loop

1. Introduction

Cervical cancer is one kind of malignant tumor in gynecology [1, 2, 3]. Death rate caused by cervical cancer in developing countries and other areas with underserved medical condition remains high [4, 5]. The paucity of effective therapies is noted by a call for accurate diagnosis and better prognosis for cervical cancer patients. Increasing evidence has exposed that non-coding RNAs (ncRNAs) exert pivotal function on the tumorigenesis and progression of human carcinomas [6, 7, 8]. Thus, exploring potent molecules for cervical cancer treatment is the main goal of this study.

MicroRNAs (miRNAs), as endogenous transcripts with almost 22 nucleotides in length, are noted as possible causative agents in cancers [9, 10]. For example, miR-9 regulates BRCA1 and ovarian carcinoma sensitivity to cisplatin and PARP repression [11]. MiR-182 contributes to the leptomeningeal diffusion of non-sonic hedgehog-medulloblastoma [12]. MiR-20a/106a-WTX pathway mediates RhoGDIa/CDC42 axis for colon cancer progression [13]. MiR-224 plays a promotive part in the progression of non-small cell lung cancer [14]. In our research, miR-204-5p was selected. Lee et al. reveals the potential of miR-204-5p in minimal deviation adenocarcinoma of uterine cervix [15]. dbDEMC 2.0 website predicts miR-204-5p is lowly expressed in cervical cancer. As a tumor suppressor, miR-204-5p has been explored in multiple tumors, such as gastric cancer, colorectal cancer, breast cancer, as well as laryngeal squamous cell carcinoma [16, 17, 18, 19]. Nevertheless, the specific mechanism of miR-204-5p in cervical cancer remains to be disentombed.

As is known to all, transcription factors can modulate the expression of target genes, positively or negatively, through interacting with their transcription start site (TSS) [20, 21]. Transcription factor AP-2 alpha (TFAP2A) is identified as a transcription factor and influences the transcription of target genes in various cancers [22, 23, 24]. TFAP2A has also been reported as an oncogene in tumors [25, 26]. University of California, Santa Cruz (UCSC) genome browser assumed the potential role of TFAP2A in regulating miR-204-5p transcription. The biological regulator role of miR-204-5p in TFAP2A-mediated function was also unraveled.

In this paper, gain-of-function assays were conducted to evaluate cellular functions after increased miR-204-5p level. Then, the downstream targets and upstream molecular mechanism of miR-204-5p were analyzed. To summarize, this study revealed the influences of miR-204-5p/TFAP2A feedback loop on cervical cancer cell functions.

2. Materials and methods

2.1 Bioinformatics analysis

The expression pattern of TFAP2A in 306 CESC (Cervical squamous cell carcinoma and endocervical adenocarcinoma) samples and 13 normal samples was obtained from Gene Expression Profiling Interactive Analysis (GEPIA) database (http://gepia.cancer-pku.cn/detail.php?gene=&clicktag=boxplot) which the expression difference between The Cancer Genome Atlas (TCGA) tumor samples and match TCGA normal and Genotype-Tissue Expression (GTEx) data.

2.2 Cell culture

The normal cervical epithelial cells (H8) and four cervical cancer cells (HeLa, CaSki, SiHa, and C33A) were attained from American Type Culture Collection (ATCC; Manassas, VA, USA). With saturated humidity at 37 ${}^{\circ}$ C containing 5% CO ${}_{2}$ , cells were cultivated in RPMI 1640 medium (Gibco, Grand Island, NY, USA) supplying with 1% penicillin/streptomycin (Gibco) and 10% FBS (Gibco).

2.3 Cell transfection

MiR-204-5p mimics, miR-NC, miR-204-5p inhibitor and miR-NC inhibitor were synthesized and obtained from GenePharma (Shanghai, China). Specific short hairpin RNA (shRNA) against TFAP2A (shTFAP2A) and shNC, along with pcDNA3.1/TFAP2A and the empty vector, were obtained from Genechem (Shanghai, China). These plasmids were separately transfected into SiHa or CaSki cells through Lipofectamine 3000 (Invitrogen, Carlsbad, CA, USA).

2.4 qRT-PCR

The extraction of total RNAs from SiHa and CaSki cells was achieved by TRIzol reagent (Invitrogen). The gene-specific primers were designed by Primer3 Input (version 0.4.0) and evaluated by Oligo 6 software. Oligo DNA was chemically synthesized by $\beta$ -dIPhosphoramidite. Then, the synthesized cDNA with specific primers was acquired using Reverse Transcription Kit (TaKaRa, Tokyo, Japan) and used as the template for PCR amplification. SYBR Green Taq Mix (Takara) was employed upon Bio-Rad Real-Time PCR System (Bio-Rad, Hercules, CA, USA) for qRT-PCR. The reaction condition was comprised of 10 min of pre-denaturation at 95 ${}^{\circ}$ C, 40 cycles of denaturation at 95 ${}^{\circ}$ C for 15 s, 1 min of annealing at 65 ${}^{\circ}$ C and 30 s of extension at 72 ${}^{\circ}$ C. 3 wells were set for every pair of primers. Gene levels were quantified in the light of 2 ${}^{-\Delta\Delta Ct}$ and normalized to GAPDH or U6. The primers for qRT-PCR were shown in Supplementary Table 1.

2.5 CCK-8 assay

Transfected SiHa or CaSki cells were cultured in 96-well dishes (2000 cells/well). Absorbance at 450 nm was read by utilizing a microplate reader after treatment for 4 h using 10- $\mu$ L CCK-8 reagent (Dojindo, Kumamoto, Japan).

2.6 EdU staining

EdU reagents (RIBOBIO, Guangzhou, China) were added for culturing transfected SiHa or CaSki cells in 96-well plates (2000 cells/well). 2 h later, cells were fastened with 4% paraformaldehyde (PFA; Sigma-Aldrich, St. Louis, MO, USA) in PBS (Sigma-Aldrich). Before incubation in 1 $\times$ Apollo solution (RIBOBIO) for 0.5 h, cells were rinsed thrice in PBS with 0.1% Triton X-100 (Sigma-Aldrich). Cells were subjected to DAPI staining (Sigma-Aldrich) for 30 min and later observed via the fluorescence microscopy (Leica, Wetzlar, Germany).

2.7 Colony formation assay

Transfected SiHa or CaSki cells were first inoculated into 6-well plates (500 cells/well), and incubated for 2 weeks. Upon this, visible colonies were counted via an inverted microscope (Olympus, Tokyo, Japan) after fixation in 4% PFA and dyeing in 0.1% crystal violet.

2.8 Wound healing assay

SiHa or CaSki cells were put in 6-well plates (1 $\times$ 10 ${}^{6}$ cells/well) and scraped using a sterile 10- $\mu$ L pipette, followed by cleaning with PBS for the removal of debris. After 24 h, migrated cells were visualized under a microscope (Olympus).

2.9 Transwell assay

A Matrigel-coated Transwell chamber with 8- $\mu$ m pore size (Corning, Cambridge, MA, USA) was applied for invasion assay. Transfected SiHa or CaSki cells were maintained with serum-free medium in the top chamber. Cell culture medium with 10% FBS was put into the lower chamber. 48 h later, invasive cells were fixed for 0.5 h through utilizing 4% formaldehyde solution (Sigma-Aldrich) and stained for a quarter in 0.1% crystal violet solution (Sigma-Aldrich). Pictures were photographed with a microscope.

2.10 RNA pull-down assay

Cell lysates of SiHa or CaSki cells were incubated with biotinylated miR-204-5p sense/antisense (named as Bio-miR-204-5p sense/antisense), compared with Bio-NC. Subsequently, magnetic beads (Invitrogen) were added. TFAP2A mRNA level was determined via qRT-PCR.

2.11 Luciferase reporter assay

The wild-type (WT) or mutant (Mut) sequences of TFAP2A 3’-UTR with or without the binding to miR-204-5p were sub-cloned into pmirGLO luciferase reporter vector (Promega, Madison, WI, USA), which were sequentially co-transfected with miR-204-5p mimics and miR-NC or miR-204-5p inhibitor and miR-NC inhibitor into SiHa or CaSki cells. The pGL3 reporter vector (Promega) containing miR-204-5p promoter was co-transfected with shTFAP2A and shNC or pcDNA3.1/TFAP2A and empty pcDNA3.1 vector into tumor cells, separately. Dual Luciferase Reporter Assay System (Promega) tested the luciferase activities.

2.12 Chromatin immunoprecipitation (ChIP)

ChIP was conducted using the Agarose ChIP Kit (Pierce). SiHa or CaSki cells were fixed in 1% formaldehyde to cross-link DNA and protein. Chromatin was digested and sonicated to chromatin fragments (200–1000 bp). The immunoprecipitation was carried out with TFAP2A or IgG antibody (Millipore, Bedford, MA, USA). The precipitated DNA was quantitated via qRT-PCR.

2.13 Western blot

Total protein was isolated from transfected SiHa or CaSki cells after treatment with RAPI protein lysate (Beyotime, Shanghai, China) and subsequently quantified using a BCA Protein Assay Kit (Pierce, Rockford, IL, USA). Protein was electro-transferred to PVDF membrane (Invitrogen) at 200 mA for 2 h upon separation by use of SDS-PAGE (Bio-Rad). Next, membranes were blocked for nearly 1 h in TBST (Sigma-Aldrich) with 5% skimmed milk and incubated for one night with primary antibodies against E-cadherin (ab40772, Abcam), Vimentin (ab8978, Abcam), N-cadherin (ab76057, Abcam), TMOD3 (ab157215, Abcam), ZNF282 (PA5-41464, Invitrogen), BIRC6 (ab19609, Abcam), TFAP2A (ab52222, Abcam) and GAPDH (ab9485, Abcam) at 4 ${}^{\circ}$ C. Next, membranes were rinsed thrice using TBST buffer and cultured for 1.5 h with secondary antibodies. Eventually, blots were visualized by ECL (Beyotime) after washing thrice.

2.14 Statistical analysis

Values were expressed as means $\pm$ SD. Statistical significances of data were analyzed using Student’s t-test (two groups), one-way or two-way ANOVA (more than groups). All statistical analyses were undertaken using Prism 5 (GraphPad, La Jolla, CA, USA). Statistically significant data were defined as those with $P$ value $<$ 0.05 was regarded as. Assays were run in triplicate.

3. Results

3.1 miR-204-5p exerted anti-cancer function in cervical cancer

At first, miR-204-5p was found to exhibit downregulation in cervical cancer cells (Fig. 1A), especially in SiHa and CaSki cells. Then, miR-204-5p was overexpressed in SiHa and CaSki cells (Fig. 1B) for gain-of-function assays. In CCK-8 assay, cell viability was repressed by enhancing the level of miR-204-5p (Fig. 1C). Data from EdU assay revealed there were lesser EdU positive cells in transfected SiHa and CaSki cells, suggesting that miR-204-5p upregulation could inhibit cell proliferation (Fig. 1D). And data from colony formation assay further revealed that miR-204-5p overexpression hampered cell proliferation (Fig. 1E). Likewise, the result of wound healing analysis revealed that cell migration was suppressed by elevating miR-204-5p expression (Fig. 1F). Meanwhile, we observed through transwell invasion assay that invasive ability was restrained by miR-204-5p mimics (Fig. 1G). Besides, western blot assay was applied to estimate the levels of proteins involved in EMT process. The result showed that overexpressing miR-204-5p increased the level of E-cadherin while had opposite impact on that of N-cadherin and Vimentin (Fig. 1H). Taken together, miR-204-5p upregulation hindered cell functions in cervical cancer.

Figure 1.

MiR-204-5p inhibited the proliferation, migration, invasion and EMT process of cervical cancer cells. A. MiR-204-5p level was revealed in normal cell (H8) and cervical cancer cells (HeLa, CaSki, SiHa, C33A) through qRT-PCR. B. The overexpression efficiency of miR-204-5p was assessed by qRT-PCR through transfection with specific miRNA mimics into SiHa and CaSki cells. C and E. CCK-8 (C), EdU staining (D) and colony formation (E) assays were performed in transfected cells for the detection of cell viability, EdU-positive cells and colonies. F. Wound healing for the migratory ability of SiHa and CaSki cells with increased level of miR-204-5p. G. Invasive SiHa and CaSki cells were measured by transwell invasion assay in response to the enhanced level of miR-204-5p. H. Western blot assay for the examination of EMT-related proteins in miR-204-5p-upregulated SiHa and CaSki cells. ${}^{\ast\ast}p<$ 0.01 vs control group.

3.2 MiR-204-5p targeted TFAP2A in cervical cancer

To explore the downstream molecular mechanism of miR-204-5p in cervical cancer, we screened from five online databases (microT, miRanda, PITA, PicTar and TargetScan) and obtained 23 shared potential targets (Fig. 2A). Afterwards, qRT-PCR detected the levels of these mRNAs in cervical cancer cells and the results were plotted into the heatmap. Four mRNAs (ZNF282, BRIC6, TMOD3 and TFAP2A) exhibited the relative highest level in tumor cells (Fig. 2B). Next, the impact of miR-204-5p on these four mRNAs was dissected. After overexpressing miR-204-5p in SiHa and CaSki cells, we detected the distinctly reduced mRNA and protein levels of TMOD3 and TFAP2A (Fig. 2C and D). In addition, the levels of these four mRNAs were also examined in SiHa and CaSki cells after inhibiting miR-204-5p expression. As a result, merely TFAP2A mRNA and protein levels were obviously augmented (Fig. 2E and F). Herein, TFAP2A was chosen for further analysis. Interestingly, TFAP2A was predicted to be highly expressed in TCGA CESC tissues (Fig. 2H). Consistently, high mRNA and protein levels of TFAP2A were observed in cervical cancer cells (Fig. 2I). Subsequently, RNA pull-down assay demonstrated that TFAP2A was only pulled down by biotinylated miR-204-5p sense (Fig. 2J). To further analyze the interaction between miR-204-5p and TFAP2A, the wild-type and mutant sequences of TFAP2A 3’-UTR for interacting with miR-204-5p and the sequences of miR-204-5p for TFAP2A 3’-UTR were predicted and presented in Fig. 2K. Through luciferase reporter assay, we observed that the luciferase activity of TFAP2A (WT) reporter was weakened by miR-204-5p upregulation whereas strengthened by miR-204-5p suppression (Fig. 2L). Altogether, we confirmed that TFAP2A was targeted by miR-204-5p.

Figure 2.

MiR-204-5p could bind to TFAP2A in cervical cancer. A and B. 23 shared target genes of miR-204-5p predicted by online datasets were presented as Venn diagram and analyzed by qRT-PCR in cervical cancer cells versus normal H8 cells. C and D. The levels of 4 possible mRNAs and corresponding proteins in SiHa and CaSki cells were evaluated using qRT-PCR and western blot after transfection. E. The inhibition of miR-204-5p expression was confirmed by qRT-PCR, compared with miR-NC group. F and G. qRT-PCR and western blot analyses of the 4 genes in SiHa and CaSki cells responding to miR-204-5p depletion. H. TFAP2A expression in CESC samples and normal samples was predicted by GEPIA database. I. qRT-PCR and western blot for TFAP2A expression in cervical cancer cells and H8 cells. J. RNA pull-down confirmed the binding capacity between TFAP2A and miR-204-5p. K. The predicted wide-type or mutant binding sequences of TFAP2A to miR-204-5p seed region. L. The interaction of TFAP2A with miR-204-5p was testified via luciferase reporter assay. ${}^{\ast}p<$ 0.05 and ${}^{\ast\ast}p<$ 0.01 vs control group.

3.3 TFAP2A and miR-204-5p constituted a feedback loop

Interestingly, TFAP2A is predicted to be a potential transcriptional regulator for miR-204-5p in accordance with the data of UCSC. Therefore, we speculated that TFAP2A and miR-204-5p might form a circuit to modulate each other. The DNA motif of TFAP2A was exhibited in Fig. 3A. ChIP experiment determined that miR-204-5p promoter was enriched in anti-TFAP2A group (Fig. 3B). After TFAP2A expression was downregulated or upregulated, the luciferase activity of miR-204-5p promoter was accordingly enhanced or impaired (Fig. 3C and D). These changes were also observed in relation to the miR-204-5p expression (Fig. 3E). Then, we continued to affirm the impact of TFAP2A and miR-204-5p on each other. MiR-204-5p expression was elevated by miR-204-5p mimics but lowered by TFAP2A upregulation (Fig. 3F). Likewise, TFAP2A levels increased by TFAP2A upregulation were decreased again by miR-204-5p mimics (Fig. 3G and H). In addition, miR-204-5p expression was enhanced by shTFAP2A but regained by miR-204-5p inhibitor (Fig. 3I). These findings illustrated that TFAP2A and miR-204-5p could form a negative feedback loop to regulate each other.

Figure 3.

TFAP2A could regulate miR-204-5p expression transcriptionally. A. The DNA motif of transcription factor TFAP2A. B. ChIP assay validated the binding of TFAP2A to miR-204-5p promoter. C. Both levels of TFAP2A mRNA and protein in SiHa and CaSki cells transfected with shTFAP2A or pcDNA3.1/TFAP2A were analyzed via qRT-PCR and western blot, with shNC or pcDNA3.1 as negative control. D. The effect of TFAP2A on miR-204-5p transcription was confirmed by luciferase reporter assay. E. The effect of TFAP2A depletion or TFAP2A overexpression on miR-204-5p expression was detected by qRT-PCR. F. MiR-204-5p level was detected in cells was examined via qRT-PCR responding to TFAP2A overexpression or knockdown. G and H. TFAP2A expression in different groups was examined via qRT-PCR and western blot. I. The expression of miR-204-5p in two cervical cancer cells was detected via qRT-PCR after indicated transfections. ${}^{\ast}p<$ 0.05 and ${}^{\ast\ast}p<$ 0.01 vs control group.

Figure 4.

MiR-204-5p/TFAP2A feedback loop regulated cell proliferation, migration, invasion and EMT process in cervical cancer. A–C. The proliferative ability of SiHa cells transfected with different plasmids was assessed via CCK-8, EdU staining and colony formation. D and E. The capabilities of transfected cells to migrate and invade were measured via wound healing and transwell assays. F. Western blot was done to examine the levels of EMT-related proteins in transfected cells. ${}^{\ast}p<$ 0.05 and ${}^{\ast\ast}p<$ 0.01 vs control group.

3.4 Upregulation of TFAP2A rescued miR-204-5p mimics-inhibited cellular activities in cervical cancer

Functional rescue assays were conducted to further confirm the role of miR-204-5p/TFAP2A feedback loop in cervical cancer. It was displayed by CCK-8 assay that overexpressed miR-204-5p inhibited cell viability, and this effect was then reversed by increased level of TFAP2A (Fig. 4A). Likewise, EdU and colony forming assays manifested that the proliferation of SiHa cells was restrained by miR-204-5p overexpression, and this phenomenon was counteracted by TFAP2A upregulation (Fig. 4B and C). Based on the results of wound healing assay, overexpression of miR-204-5p repressed cell migratory capacity, which was then neutralized by overexpressing TFAP2A (Fig. 4D). In transwell assay, we observed that TFAP2A overexpression rescued the suppressive influence of miR-204-5p upregulation on cell invasion (Fig. 4E). Moreover, western blot elucidated that E-cadherin expression was augmented by upregulation of miR-204-5p, which was then reversed by TFAP2A overexpression. Conversely, N-cadherin and Vimentin protein levels were lowered by elevating miR-204-5p expression, which was then increased by overexpressing TFAP2A (Fig. 4F). In summary, miR-204-5p/TFAP2A feedback loop contributed to the proliferative and motorial abilities of cervical cancer cells.

4. Discussion

It is full of challenges to seek for effective therapies for cervical cancer. Therefore, the research for promising biomarkers potentiating the pathology of cervical cancer is significant. In the past decades, the roles of microRNAs (miRNAs) in cervical cancer have been widely explored. For instance, miR-506 suppresses cervical cancer by directly targeting Gli3, a transcription factor of the hedgehog pathway [27]. Up-regulation of B4GALT3 targeted by miR-27a contributes to cervical cancer cells [28]. Repressed miR-126 and upregulated adrenomedullin by cancer-stromal cross talks in the stromal endothelium provoke the angiogenesis of cervical cancer [29]. Suppression of miR-424 and upregulation of Chk1 contribute to cervical cancer progression [30]. As previously reported, miR-204-5p was under-expressed in minimal deviation adenocarcinoma of uterine cervix [15]. What’s more, miR-204-5p was also supposed to be expressed at low levels in cervical cancer. In our current study, we determined that the miR-204-5p exerted anti-oncogenic role in cervical cancer by suppressing cell growth and migration.

Mechanistically, miRNAs usually regulate their downstream mRNA by post-transcriptional regulation [34]. Here, we explored and identified that TFAP2A was the direct target of miR-204-5p. Importantly, past studies have reported that TFAP2A is a tumor promoter by serving as a transcriptional regulator [24, 25]. It is known that miRNAs can be activated or suppressed by their upstream modulators [35, 36]. For example, Cip2a/miR-301a feedback loop facilitates triple-negative breast cancer cell proliferation and invasion [37]. MiR-29a-5p/STAT3 feedback loop mediates the progression of colitis-associated colorectal cancer [38]. TNF- $\alpha$ forms a feedback loop with miR-155 in osteosarcoma cancer stem cells [39]. ARRDC3/miR-200b feedback loop regulates chemo-resistance of triple-negative breast cancer [40]. On this basis, we also detected the regulatory role of TFAP2A for miR-204-5p transcription. Searching on online database, TFAP2A was in the upstream of miR-204-5p. Mechanism experiments prompted us to conclude that TFAP2A transcriptionally inactivated miR-204-5p. Final rescue experiments revealed that TFAP2A overexpression reversed the suppressive influence of miR-204-5p upregulation on cervical cancer cell proliferation, migration, invasion and EMT process. Consistent with previous researches, our study revealed the mutual regulation between miRNA and mRNA. But differently, our research was the first to unravel miR-204-5p/TFAP2A feedback loop in cervical cancer.

In summary, this paper disclosed a feedback loop of miR-204-5p with TFAP2A for the modulation of cellular processes in cervical cancer. MiR-204-5p could repress TFAP2A expression at post-transcriptional level, and TFAP2A could in turn inactivate miR-204-5p expression at transcriptional level. These findings suggested that targeting miR-204-5p/TFAP2A might be a prospective therapy for the treatment of cervical cancer patients.

Footnotes

Acknowledgments

All supports in this research were undeniable.

Conflict of interest

None.

Supplementary data

The supplementary files are available to download from http://dx.doi.org/10.3233/CBM-191064.

References

Tian

Wang

Zang

Chen

Yao

and Li

, The characteristics of HPV integration in cervical intraepithelial cells, J Cancer 10 (2019), 2783–2787.

Zhang

J.J.

and Fan

L.P.

, Long non-coding RNA CRNDE enhances cervical cancer progression by suppressing PUMA expression, Biomed Pharmacother 117 (2019), 108726.

Andersen

Christensen

B.S.

Christensen

Ejersbo

Heje

H.N.

Jochumsen

K.M.

Johansen

Larsen

L.G.

Lynge

Serizawa

Viborg

P.H.

and Waldstrøm

, HPV-prevalence in elderly women in Denmark, Gynecol Oncol (2019).

Kundrod

K.A.

Smith

C.A.

Hunt

Schwarz

R.A.

Schmeler

and Richards-Kortum

, Advances in technologies for cervical cancer detection in low-resource settings, Expert Rev Mol Diagn (2019), 1–19.

Tawe

MacDuffie

Narasimhamurthy

Wang

Gaseitsiwe

Moyo

Kasvosve

Shin

S.S.

Zetola

N.M.

Paganotti

G.M.

and Grover

, Human Papillomavirus (HPV) Genotypes in Women with Invasive Cervical Cancer with and without Human Immunodeficiency Virus (HIV) Infection in Botswana, Int J Cancer (2019).

Ponting

C.P.

Oliver

P.L.

and Reik

, Evolution and functions of long noncoding RNAs, Cell 136 (2009), 629–41.

Barrett

S.P.

and Salzman

, Circular RNAs: analysis, expression and potential functions, Development 143 (2016), 1838–47.

Bartel

D.P.

, MicroRNAs: Genomics, biogenesis, mechanism, and function, Cell 116 (2004), 281–97.

Hwang

H.W.

and Mendell

J.T.

, MicroRNAs in cell proliferation, cell death, and tumorigenesis, Br J Cancer 94 (2006), 776–80.

10.

Jiang

Zhang

H.W.

M.H.

X.H.

Liu

M.F.

and Wang

E.D.

, MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene, Cancer Res 70 (2010), 3119–27.

11.

Sun

Yang

Zhou

Weng

Fang

Chen

Yang

Zhou

and Chen

, miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition, J Natl Cancer Inst 105 (2013), 1750–8.

12.

Bai

A.H.

Milde

Remke

Rolli

C.G.

Hielscher

Cho

Y.J.

Kool

Northcott

P.A.

Jugold

Bazhin

A.V.

Eichmüller

S.B.

Kulozik

A.E.

Pscherer

Benner

Taylor

M.D.

Pomeroy

S.L.

Kemkemer

Witt

Korshunov

Lichter

and Pfister

S.M.

, MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma, Acta Neuropathol 123 (2012), 529–38.

13.

Zhu

G.F.

Y.W.

Niu

H.L.

W.X.

Zhou

P.R.

Liu

D.L.

Liu

X.R.

Yan

Zhai

W.K.

Z.J.

Liu

Wang

Luo

J.M.

Liu

X.Q.

Guo

Jiang

H.P.

Shen

Lin

H.K.

D.H.

Ding

Y.Q.

and Zhang

Q.L.

, Mir20a/106a-WTX axis regulates RhoGDIa/CDC42 signaling and colon cancer progression, Nat Commun 10 (2019), 112.

14.

Cui

Meng

Sun

H.L.

Kim

Fassan

Jeon

Y.J.

Vicentini

Peng

Lee

T.J.

Luo

Liu

Tili

Jin

Middleton

Chakravarti

Lautenschlaeger

and Croce

C.M.

, MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer, Proc Natl Acad Sci USA (2015).

15.

Lee

Kim

K.R.

Cho

N.H.

Hong

S.R.

Jeong

Kwon

S.Y.

Park

K.H.

H.J.

Kim

T.H.

Kim

Yoon

H.K.

Suh

K.S.

Min

K.O.

Choi

H.J.

Park

J.Y.

Yoo

C.W.

Lee

Y.S.

Lee

H.J.

Lee

W.S.

Park

C.S.

and Lee

, MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix, World J Surg Oncol 12 (2014), 334.

16.

Chen

Nie

Yan

Chen

Wei

Ren

Wang

and Sun

, Long noncoding RNA LINC01234 functions as a competing endogenous RNA to regulate CBFB expression by sponging miR-204-5p in gastric cancer, Clin Cancer Res (2018).

17.

Yin

Zhang

Wang

Fei

Quan

Zhang

Song

Bian

Wang

Mao

Zhou

Wang

Hua

and Huang

, miR-204-5p inhibits proliferation and invasion and enhances chemotherapeutic sensitivity of colorectal cancer cells by downregulating RAB22A, Clin Cancer Res 20 (2014), 6187–99.

18.

Liang

W.H.

Yuan

Z.Q.

Qian

X.L.

and Wang

Z.H.

, DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2, Mol Carcinog (2018).

19.

Gao

Zhang

Zhu

Chen

Liu

Wen

and Wang

, MicroRNA-204-5p inhibits invasion and metastasis of laryngeal squamous cell carcinoma by suppressing forkhead box C1, J Cancer 8 (2017), 2356–2368.

20.

Haberle

Hadzhiev

Plessy

Previti

Nepal

Gehrig

Dong

Akalin

Suzuki

A.M.

van

I.W.F.

Armant

Ferg

Strähle

Carninci

Müller

and Lenhard

, Two independent transcription initiation codes overlap on vertebrate core promoters, Nature 507 (2014), 381–5.

21.

Soboleva

T.A.

Nekrasov

Pahwa

Williams

Huttley

G.A.

and Tremethick

D.J.

, A unique H2A histone variant occupies the transcriptional start site of active genes, Nat Struct Mol Biol 19 (2012), 25–30.

22.

Tucker

N.R.

Weng

L.C.

Clauss

Lubitz

S.A.

and Ellinor

P.T.

, A Functional Variant Associated with Atrial Fibrillation Regulates PITX2c Expression through TFAP2a, Am J Hum Genet (2016).

23.

Krendl

Shaposhnikov

Rishko

Ori

Ziegenhain

Sass

Simon

Müller

N.S.

Straub

Brooks

K.E.

Chavez

S.L.

Enard

Theis

F.J.

and Drukker

, GATA2/3-TFAP2A/C transcription factor network couples human pluripotent stem cell differentiation to trophectoderm with repression of pluripotency, Proc Natl Acad Sci USA (2017).

24.

Chen

Wang

Gao

Miao

and Ren

, MiR-1254 suppresses HO-1 expression through seed region-dependent silencing and non-seed interaction with TFAP2A transcript to attenuate NSCLC growth, PLoS Genet 13 (2017), e1006896.

25.

Cao

Wang

Zhang

Wong

K.C.

Nakatsu

Wang

Wong

and Yu

, Zinc-finger protein 471 suppresses gastric cancer through transcriptionally repressing downstream oncogenic PLS3 and TFAP2A, Oncogene (2018).

26.

Schulte

J.H.

Kirfel

Lim

Schramm

Friedrichs

Deubzer

H.E.

Witt

Eggert

and Buettner

, Transcription factor AP2alpha (TFAP2a) regulates differentiation and proliferation of neuroblastoma cells, Cancer Lett 271 (2008), 56–63.

27.

Wen

S.Y.

Lin

Y.Q.

Cao

S.J.

Zhang

Yang

X.M.

Zhang

Y.L.

Wang

Y.H.

M.Z.

Sun

W.W.

Lou

X.L.

Wang

J.H.

Teng

Y.C.

and Zhang

Z.G.

, miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer, Oncogene 34 (2015), 717–25.

28.

Sun

Yang

Liu

and Tang

, B4GALT3 up-regulation by miR-27a contributes to the oncogenic activity in human cervical cancer cells, Cancer Lett 375 (2016), 284–92.

29.

Huang

T.H.

and Chu

T.Y.

, Repression of miR-126 and upregulation of adrenomedullin in the stromal endothelium by cancer-stromal cross talks confers angiogenesis of cervical cancer, Oncogene 33 (2014), 3636–47.

30.

Wang

Cheng

Xie

Zhou

and Lu

, Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer, Oncogene 32 (2013), 976–87.

31.

Díaz-Martínez

Benito-Jardón

Alonso

Koetz-Ploch

Hernando

and Teixido

, miR-204-5p and miR-211-5p contribute to BRAF inhibitor resistance in melanoma, Cancer Res (2017).

32.

Bian

Jin

Zhang

Yin

Quan

Feng

Liu

Fei

Mao

Zhou

Huang

Hua

Xing

and Huang

, LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p, Sci Rep 6 (2016), 23892.

33.

Xia

Liu

Zhang

and Liu

, Decreased expression of MiRNA-204-5p contributes to glioma progression and promotes glioma cell growth, migration and invasion, PLoS ONE 10 (2015), e0132399.

34.

Ghazwani

Zhang

Fan

Gandhi

C.R.

and Li

, miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression, J Hepatol 58 (2013), 522–8.

35.

Liang

Qin

and Zhai

, MiR-374b-5p-FOXP1 feedback loop regulates cell migration, epithelial-mesenchymal transition and chemosensitivity in ovarian cancer, Biochem Biophys Res Commun 505 (2018), 554–560.

36.

Cheng

Shi

Huo

Zhao

and Zhang

, MiR-449b-5p regulates cell proliferation, migration and radioresistance in cervical cancer by interacting with the transcription suppressor FOXP1, Eur J Pharmacol 856 (2019), 172399.

37.

Yin

Chen

Luo

Zeng

Chen

Song

Zhang

Zheng

and Liu

, Cip2a/miR-301a feedback loop promotes cell proliferation and invasion of triple-negative breast cancer, J Cancer 10 (2019), 5964–5974.

38.

Wang

Deng

Chen

and Li

, miR-29a-5p/STAT3 Positive Feedback Loop Regulates TETs in Colitis-Associated Colorectal Cancer, Inflamm Bowel Dis 26 (2020), 524–533.

39.

Yao

Lin

Huang

and Liu

, TNF-alpha/miR-155 axis induces the transformation of osteosarcoma cancer stem cells independent of TP53INP1, Gene 726 (2020), 144224.

40.

Soung

Y.H.

Chung

Yan

and Chung

, Arrestin Domain Containing 3 Reverses Epithelial to Mesenchymal Transition and Chemo-Resistance of TNBC Cells by Up-Regulating Expression of miR-200b, Cells 8 (2019).

MiR-204-5p/TFAP2A feedback loop positively regulates the proliferation,migration,invasion and EMT process in cervical cancer

Abstract

Keywords

1. Introduction

2. Materials and methods

2.1 Bioinformatics analysis

2.2 Cell culture

2.3 Cell transfection

2.4 qRT-PCR

2.5 CCK-8 assay

2.6 EdU staining

2.7 Colony formation assay

2.8 Wound healing assay

2.9 Transwell assay

2.10 RNA pull-down assay

2.11 Luciferase reporter assay

2.12 Chromatin immunoprecipitation (ChIP)

2.13 Western blot

2.14 Statistical analysis

3. Results

3.1 miR-204-5p exerted anti-cancer function in cervical cancer

4. Discussion

Footnotes

Acknowledgments

Conflict of interest

Supplementary data

References